161 related articles for article (PubMed ID: 21856557)
1. Soluble biomarkers in psoriasis.
Enerbäck C
Eur J Dermatol; 2011; 21(6):844-50. PubMed ID: 21856557
[TBL] [Abstract][Full Text] [Related]
2. Soluble biomarkers may differentiate psoriasis from psoriatic arthritis.
Chandran V
J Rheumatol Suppl; 2012 Jul; 89():65-6. PubMed ID: 22751596
[TBL] [Abstract][Full Text] [Related]
3. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive review of biomarkers in psoriasis.
Rashmi R; Rao KS; Basavaraj KH
Clin Exp Dermatol; 2009 Aug; 34(6):658-63. PubMed ID: 19558584
[TBL] [Abstract][Full Text] [Related]
5. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis.
Chandran V; Cook RJ; Edwin J; Shen H; Pellett FJ; Shanmugarajah S; Rosen CF; Gladman DD
Rheumatology (Oxford); 2010 Jul; 49(7):1399-405. PubMed ID: 20421218
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008.
Ritchlin CT; Qureshi AA; de Vlam K; Pitzalis C; Helliwell PS; Mease PJ; Gladman DD; Krueger GG; Kavanaugh AF; Fitzgerald O
J Rheumatol; 2010 Feb; 37(2):462-7. PubMed ID: 20147482
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers and prognostic stratification in psoriatic arthritis.
Bogliolo L; Crepaldi G; Caporali R
Reumatismo; 2012 Jun; 64(2):88-98. PubMed ID: 22690385
[TBL] [Abstract][Full Text] [Related]
8. Psoriatic arthritis: a clinical entity distinct from psoriasis?
Ruiz DG; Azevedo MN; Santos OL
Rev Bras Reumatol; 2012 Aug; 52(4):630-8. PubMed ID: 22885427
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
Gisondi P; Girolomoni G
Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis: comorbidities and associations.
Farley E; Menter A
G Ital Dermatol Venereol; 2011 Feb; 146(1):9-15. PubMed ID: 21317853
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and metabolic risk profile in German patients with moderate and severe psoriasis: a case control study.
Warnecke C; Manousaridis I; Herr R; Terris DD; Goebeler M; Goerdt S; Peitsch WK
Eur J Dermatol; 2011; 21(5):761-70. PubMed ID: 21737374
[TBL] [Abstract][Full Text] [Related]
12. Research gaps in psoriasis: opportunities for future studies.
Ryan C; Korman NJ; Gelfand JM; Lim HW; Elmets CA; Feldman SR; Gottlieb AB; Koo JY; Lebwohl M; Leonardi CL; Van Voorhees AS; Bhushan R; Menter A
J Am Acad Dermatol; 2014 Jan; 70(1):146-67. PubMed ID: 24126079
[TBL] [Abstract][Full Text] [Related]
13. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
14. Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms.
Rodríguez-Cerdeira C; Molares-Vila A; Sánchez-Blanco E; Sánchez-Blanco B
Open Biochem J; 2014; 8():21-34. PubMed ID: 24688608
[TBL] [Abstract][Full Text] [Related]
15. Biological biomarkers in psoriatic disease. A review.
de Vlam K; Gottlieb AB; Fitzgerald O
J Rheumatol; 2008 Jul; 35(7):1443-8. PubMed ID: 18609742
[TBL] [Abstract][Full Text] [Related]
16. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?
Lotti T; Hercogova J; Prignano F
Dermatol Ther; 2010; 23(2):119-22. PubMed ID: 20415818
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis.
Haroon M; Adeeb F; Devlin J; O Gradaigh D; Walker F
Int J Rheum Dis; 2011 Aug; 14(3):255-60. PubMed ID: 21816021
[TBL] [Abstract][Full Text] [Related]
18. [Psoriasis and oxidative stress].
Péter I; Jagicza A; Ajtay Z; Kiss I; Németh B
Orv Hetil; 2016 Nov; 157(45):1781-1785. PubMed ID: 27817235
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory biomarkers and cardiovascular risk: association or cause and effect?
Rao M; Jaber BL; Balakrishnan VS
Semin Dial; 2006; 19(2):129-35. PubMed ID: 16551290
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for the prediction of mortality and morbidity in patients with renal replacement therapy.
Chaykovska L; Tsuprykov O; Hocher B
Clin Lab; 2011; 57(7-8):455-67. PubMed ID: 21888009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
